توقعات سوق تجزئة البلازما في أوروبا حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي حسب المنتج (الجلوبيولين المناعي، والألبومين، ومركزات عوامل التخثر، ومثبطات الأنزيم البروتيني، ومنتجات البلازما الأخرى)، والتطبيق (علم الأعصاب، وعلم المناعة، وأمراض الدم، والرعاية الحرجة، وأمراض الرئة، وغيرها) التطبيقات)، والمستخدم النهائي (المستشفيات والعيادات، ومختبرات الأبحاث السريرية، والمعاهد الأكاديمية)

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Plasma Fractionation Market – By Product

1.3.2        Europe Plasma Fractionation Market – By Application

1.3.3        Europe Plasma Fractionation Market – By End User

1.3.4        Europe Plasma Fractionation Market – By Country

2.           Europe Plasma Fractionation Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Plasma Fractionation Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Plasma Fractionation Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Plasma Therapy Being Widely Used

5.1.2        Market is Developing Due to Active Participation of the Key Players

5.2         Market Restraints

5.2.1        Alternate Non-Plasma Substitutes Available

5.3         Future Trends

5.3.1        Novel Diseases Getting Treated By Using Plasma Therapy

5.4         Impact Analysis

6.           Plasma Fractionation Market – Europe Analysis

6.1         Europe Plasma Fractionation Market Revenue Forecast and Analysis

7.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         Europe Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3         Immunoglobulin

7.3.1        Overview

7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1          Intravenous Immunoglobulin (IVIG)

7.3.2.1.1          Overview

7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2          Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1          Overview

7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Albumin

7.4.1        Overview

7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Coagulation Factor Concentrates

7.5.1        Overview

7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Protease Inhibitors

7.6.1        Overview

7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Other Plasma Products

7.7.1        Overview

7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3         Neurology

8.3.1        Overview

8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Immunology

8.4.1        Overview

8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Hematology

8.5.1        Overview

8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Critical Care

8.6.1        Overview

8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Pulmonology

8.7.1        Overview

8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Other Applications

8.8.1        Overview

8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.           Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Clinical Research Laboratories

9.4.1        Overview

9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Academic Institutes

9.5.1        Overview

9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10.        Europe Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

10.1.1.1       Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3.1    Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4       Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5       Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3.1    France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4       France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5       France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3.1    UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4       UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5       UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3.1    Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4       Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5       Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5       Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3.1    Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.4       Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5       Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6       Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3.1    Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4       Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5       Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Europe Plasma Fractionation Market

11.1      Europe: Impact Assessment Of COVID-19 Pandemic

12.        Plasma Fractionation Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Followed by Major Market Players (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic developments

12.4.1     Overview

13.        Company Profiles

13.1      Biotest AG.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Octapharma AG

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Kedrion S.p.A

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      CSL Limited

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Grifols, S.A.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bio Products Laboratory Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Sanquin

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Bharat Serums and Vaccines Limited (BSV)

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      SK Plasma

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 6.             France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 10.          UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic developments done by Companies

Table 27.          Glossary of Terms, Plasma Fractionation Market

LIST OF FIGURES

Figure 1.           Europe Plasma Fractionation Market Segmentation

Figure 2.           Europe Plasma Fractionation Market Segmentation, By Country

Figure 3.           Europe Plasma Fractionation Market Overview

Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in Europe Plasma Fractionation Market

Figure 5.           Germany to Show Significant Growth During Forecast Period

Figure 6.           Europe and PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to Europe Plasma Fractionation Market

Figure 8.           Europe Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9.           Europe Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10.        Europe Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        Europe Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Europe Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        Europe Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16.        Europe Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18.        Europe Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        Europe Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        Europe Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        Europe Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22.        Europe Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23.        Europe Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24.        Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25.        Europe Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26.        Europe Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27.        Europe Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28.        Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)

Figure 29.        Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)

Figure 30.        Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Impact of COVID-19 Pandemic in European Country Markets

1. Bharat Serums and Vaccines Limited (BSV)
2. Bio Products Laboratory Ltd.
3. Biotest AG.
4. CSL Limited
5. Grifols, S.A.
6. Kedrion S.p.A
7. Octapharma AG
8. Sanquin
9. SK Plasma

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plasma fractionation market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution